Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
Categories
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Pharma Has a Pull-Through Problem; The Answer is Data
Pharma Has a Pull-Through Problem; The Answer is Data
Are Alternative Distribution Models a Viable Option for Pharma?
As seen in Pharmaceutical Commerce: Key considerations for drug manufacturers pursuing an effective alternative distribution model
The Perils of Pull-Through
The Perils of Pull-Through
6 Essential Strategies for Successful Clinical Adherence
6 Essential Strategies for Successful Clinical Adherence
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
How Product Acquisition Impacts Patient Support Offerings: Buy and Bill vs. Specialty Pharmacy
Product Acquistion (Buy and Bill vs. Specialty Pharmacy) is a key factor in determining which services a HUB should offer
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|